Lung surfactants/mucolytics:
Indications for: PULMOZYME
Management of cystic fibrosis in conjunction with standard therapies to improve pulmonary function.
Adults and Children:
<3months: not recommended. Use appropriate nebulizer. Do not dilute. >5yrs: 2.5mg once daily via nebulization; may increase to 2.5mg twice daily (see literature).
PULMOZYME Warnings/Precautions:
For patients <5yrs of age, use only if there is a potential for benefit in pulmonary function or in risk of respiratory tract infection. Use only with recommended nebulizers. Pregnancy (Cat.B). Nursing mothers.
PULMOZYME Interactions:
Do not mix with other drugs in nebulizer.
Adverse Reactions:
Pharyngitis, voice alteration, laryngitis, rash, chest pain, conjunctivitis.
How Supplied:
Amps (2.5mL)—30
